Asset
Boron
Emergent BioSolutions Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00636519 | phase1 | completed | 2008-02-01 | 2009-10-01 | Emergent BioSolutions | Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 125462 | BLA | Emergent BioSolutions Canada Inc. |
Marketed products (1)
- Bat